Cargando…
(5) COVID-19 Vaccination Strategies in Solid Organ Transplant Recipients: A Living Systematic Review and Network Meta-Analysis
PURPOSE: The optimal COVID-19 vaccination strategy in solid organ transplant recipients (SOTRs) remains unclear. We conducted a living systematic review and network meta-analysis (NMA) to explore COVID-19 vaccination strategies in SOTRs. METHODS: We conducted a search of databases from inception to...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068059/ http://dx.doi.org/10.1016/j.healun.2023.02.021 |
_version_ | 1785018606731395072 |
---|---|
author | Rayner, D.G. Nunes, J.T. Chu, A. Orchanian-Cheff, A. Foroutan, F. Rotstein, C. Ross, H.J. Aleksova, N. |
author_facet | Rayner, D.G. Nunes, J.T. Chu, A. Orchanian-Cheff, A. Foroutan, F. Rotstein, C. Ross, H.J. Aleksova, N. |
author_sort | Rayner, D.G. |
collection | PubMed |
description | PURPOSE: The optimal COVID-19 vaccination strategy in solid organ transplant recipients (SOTRs) remains unclear. We conducted a living systematic review and network meta-analysis (NMA) to explore COVID-19 vaccination strategies in SOTRs. METHODS: We conducted a search of databases from inception to July 2022 for all studies comparing any COVID-19 vaccination strategy in SOTRs. We performed a NMA to evaluate the impact of various vaccination strategies on COVID-19 infection, and COVID-related mortality. We used the GRADE approach for NMA to judge our certainty in the evidence. RESULTS: Of 2,534 publications identified, 27 proved eligible (4 RCTs, 23 observational). Identified RCTs were only subject to narrative summarization due to heterogeneity in their research questions (Figure A). Nine observational studies (76,703 SOTRs, 6.3% heart transplant, 5.2% lung transplant) reported adjusted hazard ratios (HRs) for COVID-19 infection and/or COVID-related mortality. The NMA for the impact of various doses of vaccines on COVID-19 infection suggested a dose-response relationship (Figure B). Compared to no vaccination, three (HR 0.16, 95%CI 0.11-0.22, moderate certainty) or two (HR 0.45, 95%CI 0.35-0.58, moderate certainty) doses of any COVID-19 vaccine showed a strong effect on reducing COVID-19 infection. One dose showed a moderate effect (HR 0.73, 95%CI 0.49-1.07, low certainty) on reducing COVID-19 infection. Two doses of any vaccine showed a moderate effect on lowering risk of mortality in COVID-19 infected SOTRs (HR 0.74, 95%CI 0.63-0.89, low certainty). We did not identify sufficient data to explore effect modification by organ group or immunosuppressant use. CONCLUSION: Current evidence suggests that increasing the number of COVID-19 vaccination doses may provide increasing protection against COVID-19 infection in SOTRs (moderate to low certainty). Further studies are needed to better understand the impact of COVID-19 vaccination on all patient-important outcomes. |
format | Online Article Text |
id | pubmed-10068059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100680592023-04-03 (5) COVID-19 Vaccination Strategies in Solid Organ Transplant Recipients: A Living Systematic Review and Network Meta-Analysis Rayner, D.G. Nunes, J.T. Chu, A. Orchanian-Cheff, A. Foroutan, F. Rotstein, C. Ross, H.J. Aleksova, N. J Heart Lung Transplant Article PURPOSE: The optimal COVID-19 vaccination strategy in solid organ transplant recipients (SOTRs) remains unclear. We conducted a living systematic review and network meta-analysis (NMA) to explore COVID-19 vaccination strategies in SOTRs. METHODS: We conducted a search of databases from inception to July 2022 for all studies comparing any COVID-19 vaccination strategy in SOTRs. We performed a NMA to evaluate the impact of various vaccination strategies on COVID-19 infection, and COVID-related mortality. We used the GRADE approach for NMA to judge our certainty in the evidence. RESULTS: Of 2,534 publications identified, 27 proved eligible (4 RCTs, 23 observational). Identified RCTs were only subject to narrative summarization due to heterogeneity in their research questions (Figure A). Nine observational studies (76,703 SOTRs, 6.3% heart transplant, 5.2% lung transplant) reported adjusted hazard ratios (HRs) for COVID-19 infection and/or COVID-related mortality. The NMA for the impact of various doses of vaccines on COVID-19 infection suggested a dose-response relationship (Figure B). Compared to no vaccination, three (HR 0.16, 95%CI 0.11-0.22, moderate certainty) or two (HR 0.45, 95%CI 0.35-0.58, moderate certainty) doses of any COVID-19 vaccine showed a strong effect on reducing COVID-19 infection. One dose showed a moderate effect (HR 0.73, 95%CI 0.49-1.07, low certainty) on reducing COVID-19 infection. Two doses of any vaccine showed a moderate effect on lowering risk of mortality in COVID-19 infected SOTRs (HR 0.74, 95%CI 0.63-0.89, low certainty). We did not identify sufficient data to explore effect modification by organ group or immunosuppressant use. CONCLUSION: Current evidence suggests that increasing the number of COVID-19 vaccination doses may provide increasing protection against COVID-19 infection in SOTRs (moderate to low certainty). Further studies are needed to better understand the impact of COVID-19 vaccination on all patient-important outcomes. Published by Elsevier Inc. 2023-04 2023-04-03 /pmc/articles/PMC10068059/ http://dx.doi.org/10.1016/j.healun.2023.02.021 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Rayner, D.G. Nunes, J.T. Chu, A. Orchanian-Cheff, A. Foroutan, F. Rotstein, C. Ross, H.J. Aleksova, N. (5) COVID-19 Vaccination Strategies in Solid Organ Transplant Recipients: A Living Systematic Review and Network Meta-Analysis |
title | (5) COVID-19 Vaccination Strategies in Solid Organ Transplant Recipients: A Living Systematic Review and Network Meta-Analysis |
title_full | (5) COVID-19 Vaccination Strategies in Solid Organ Transplant Recipients: A Living Systematic Review and Network Meta-Analysis |
title_fullStr | (5) COVID-19 Vaccination Strategies in Solid Organ Transplant Recipients: A Living Systematic Review and Network Meta-Analysis |
title_full_unstemmed | (5) COVID-19 Vaccination Strategies in Solid Organ Transplant Recipients: A Living Systematic Review and Network Meta-Analysis |
title_short | (5) COVID-19 Vaccination Strategies in Solid Organ Transplant Recipients: A Living Systematic Review and Network Meta-Analysis |
title_sort | (5) covid-19 vaccination strategies in solid organ transplant recipients: a living systematic review and network meta-analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068059/ http://dx.doi.org/10.1016/j.healun.2023.02.021 |
work_keys_str_mv | AT raynerdg 5covid19vaccinationstrategiesinsolidorgantransplantrecipientsalivingsystematicreviewandnetworkmetaanalysis AT nunesjt 5covid19vaccinationstrategiesinsolidorgantransplantrecipientsalivingsystematicreviewandnetworkmetaanalysis AT chua 5covid19vaccinationstrategiesinsolidorgantransplantrecipientsalivingsystematicreviewandnetworkmetaanalysis AT orchaniancheffa 5covid19vaccinationstrategiesinsolidorgantransplantrecipientsalivingsystematicreviewandnetworkmetaanalysis AT foroutanf 5covid19vaccinationstrategiesinsolidorgantransplantrecipientsalivingsystematicreviewandnetworkmetaanalysis AT rotsteinc 5covid19vaccinationstrategiesinsolidorgantransplantrecipientsalivingsystematicreviewandnetworkmetaanalysis AT rosshj 5covid19vaccinationstrategiesinsolidorgantransplantrecipientsalivingsystematicreviewandnetworkmetaanalysis AT aleksovan 5covid19vaccinationstrategiesinsolidorgantransplantrecipientsalivingsystematicreviewandnetworkmetaanalysis |